共 10 条
[1]
A novel combretastatin A-4 derivative, AC7700, strongly stanches tumour blood flow and inhibits growth of tumours develop ing various tissues and organs. Hori K,Saito S,Kubota K. British Journal of Cancer . 2002
[2]
Synthesis of isocombretastatins A-C. Singh SB,Pettit GR. Synthetic Communications . 1987
[3]
Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature. Dark GG,H ill SA,Prise VE,et al. Cancer Research . 1997
[4]
Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature. Dark GG,H ill SA,Prise VE,et al. Cancer Research . 1997
[5]
Structural requirements for the interaction of combretastatinswith tubulin: how important is the trimethoxy unit. Keira G,John A H,N icholas JL,et al. Organic and Biomolecular Chemistry . 2003
[6]
Isolation structure and synthesis of Combretastatin C-1. Singh SB,Pettit GR. Journal of Organic Chemistry . 1985
[7]
Synthesis and biological evaluation of aryl azide derivatives of Combretastatin A-4 as molecular probes for tubulin. Kevin GP,Maria PM,V ictorMV,et al. B ioorg Med Chem Lett . 2000
[8]
Synthesis of natural (-)-combretastatin. Pettit GR,Singh SB. Journal of Organic Chemistry . 1985
[9]
Synthesis ans structure-activity relationship of 2-am imobenzophenone derivatives as antim itotic agents. Liou JP,Chang CW,Song JS,et al. Journal of Medicinal Chemistry . 2002
[10]
Designing therap ies that target tumour blood vessels. BerinagaM. Science . 1997